Stock Traders Buy High Volume of Sanofi Put Options (NASDAQ:SNY)

Sanofi (NASDAQ:SNY) saw some unusual options trading on Monday. Stock investors acquired 2,013 put options on the company. This is an increase of approximately 68% compared to the typical daily volume of 1,201 put options.

Institutional Investors Weigh In On Sanofi

A number of large investors have recently modified their holdings of the business. Dimensional Fund Advisors LP raised its holdings in Sanofi by 0.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 318,760 shares of the company’s stock valued at $15,466,000 after buying an additional 1,238 shares during the period. AQR Capital Management LLC acquired a new position in Sanofi during the 2nd quarter worth about $344,000. The Manufacturers Life Insurance Company increased its stake in Sanofi by 27.3% during the second quarter. The Manufacturers Life Insurance Company now owns 31,528 shares of the company’s stock worth $1,530,000 after purchasing an additional 6,756 shares during the period. Creative Planning boosted its stake in shares of Sanofi by 9.2% in the second quarter. Creative Planning now owns 187,035 shares of the company’s stock valued at $9,075,000 after purchasing an additional 15,749 shares during the period. Finally, NewEdge Advisors LLC boosted its position in Sanofi by 27.2% in the 2nd quarter. NewEdge Advisors LLC now owns 29,587 shares of the company’s stock valued at $1,436,000 after buying an additional 6,330 shares during the period. Hedge funds and other institutional investors own 14.04% of the company’s stock.

Sanofi Stock Performance

SNY stock traded up $0.86 during trading on Monday, hitting $53.34. 626,291 shares of the company traded hands, compared to its average volume of 2,378,138. Sanofi has a 1 year low of $45.22 and a 1 year high of $58.97. The company has a market cap of $135.36 billion, a PE ratio of 27.25, a P/E/G ratio of 1.19 and a beta of 0.57. The stock’s 50-day simple moving average is $48.70 and its 200 day simple moving average is $52.20. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65.

Sanofi (NASDAQ:SNY) last released its quarterly earnings results on Friday, October 25th. The company reported $1.57 EPS for the quarter, beating the consensus estimate of $0.22 by $1.35. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. The company had revenue of $13.44 billion for the quarter, compared to analyst estimates of $16.59 billion. During the same quarter last year, the business earned $2.55 earnings per share. The firm’s revenue was up 12.3% on a year-over-year basis. On average, equities analysts expect that Sanofi will post 3.82 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, StockNews.com cut shares of Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.